AstraZeneca rejects new Pfizer bid

AstraZeneca has rejected a final £69bn takeover offer from US drugs giant Pfizer, saying it undervalued the company.

AstraZeneca rejects new Pfizer bid

AstraZeneca has rejected a final £69bn takeover offer from US drugs giant Pfizer, saying it undervalued the company.

The UK-based pharmaceuticals firm spurned the latest advance from the Viagra maker after it upped the price it was prepared to pay over the weekend.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited